231 related articles for article (PubMed ID: 33084842)
41. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
[TBL] [Abstract][Full Text] [Related]
42. Association of functional variant in GDF1 promoter with risk of congenital heart disease and its regulation by Nkx2.5.
Gao X; Zheng P; Yang L; Luo H; Zhang C; Qiu Y; Huang G; Sheng W; Ma X; Lu C
Clin Sci (Lond); 2019 Jun; 133(12):1281-1295. PubMed ID: 31171573
[TBL] [Abstract][Full Text] [Related]
43. A Functional Aryl Hydrocarbon Receptor Genetic Variant, Alone and in Combination with Parental Exposure, is a Risk Factor for Congenital Heart Disease.
Pulignani S; Borghini A; Vecoli C; Foffa I; Ait-Ali L; Andreassi MG
Cardiovasc Toxicol; 2018 Jun; 18(3):261-267. PubMed ID: 29185192
[TBL] [Abstract][Full Text] [Related]
44. KLF13 loss-of-function variation contributes to familial congenital heart defects.
Wang SS; Wang TM; Qiao XH; Huang RT; Xue S; Dong BB; Xu YJ; Liu XY; Yang YQ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11273-11285. PubMed ID: 33215447
[TBL] [Abstract][Full Text] [Related]
45. Risk Variants in the Exomes of Children With Critical Illness.
Motelow JE; Lippa NC; Hostyk J; Feldman E; Nelligan M; Ren Z; Alkelai A; Milner JD; Gharavi AG; Tang Y; Goldstein DB; Kernie SG
JAMA Netw Open; 2022 Oct; 5(10):e2239122. PubMed ID: 36306130
[TBL] [Abstract][Full Text] [Related]
46. Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics.
Siegel DH; Cottrell CE; Streicher JL; Schilter KF; Basel DG; Baselga E; Burrows PE; Ciliberto HM; Vigh-Conrad KA; Eichenfield LF; Holland KE; Hogeling M; Jensen JN; Kelly ME; Kim W; King DM; McCuaig C; Mueller KA; Pope E; Powell J; Price H; Steiner JE; Frieden IJ; Tollefson MM; Drolet BA
J Invest Dermatol; 2018 Apr; 138(4):957-967. PubMed ID: 29174369
[TBL] [Abstract][Full Text] [Related]
47. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
48. Relationship of the MTHFD1 (rs2236225), eNOS (rs1799983), CBS (rs2850144) and ACE (rs4343) gene polymorphisms in a population of Iranian pediatric patients with congenital heart defects.
Khatami M; Ratki FM; Tajfar S; Akrami F
Kaohsiung J Med Sci; 2017 Sep; 33(9):442-448. PubMed ID: 28865601
[TBL] [Abstract][Full Text] [Related]
49. Whole exome sequencing in 342 congenital cardiac left sided lesion cases reveals extensive genetic heterogeneity and complex inheritance patterns.
Li AH; Hanchard NA; Furthner D; Fernbach S; Azamian M; Nicosia A; Rosenfeld J; Muzny D; D'Alessandro LCA; Morris S; Jhangiani S; Parekh DR; Franklin WJ; Lewin M; Towbin JA; Penny DJ; Fraser CD; Martin JF; Eng C; Lupski JR; Gibbs RA; Boerwinkle E; Belmont JW
Genome Med; 2017 Oct; 9(1):95. PubMed ID: 29089047
[TBL] [Abstract][Full Text] [Related]
50. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease.
Junker R; Kotthoff S; Vielhaber H; Halimeh S; Kosch A; Koch HG; Kassenböhmer R; Heineking B; Nowak-Göttl U
Cardiovasc Res; 2001 Aug; 51(2):251-4. PubMed ID: 11470464
[TBL] [Abstract][Full Text] [Related]
51. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK
Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972
[TBL] [Abstract][Full Text] [Related]
52. A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data.
Szot JO; Cuny H; Blue GM; Humphreys DT; Ip E; Harrison K; Sholler GF; Giannoulatou E; Leo P; Duncan EL; Sparrow DB; Ho JWK; Graham RM; Pachter N; Chapman G; Winlaw DS; Dunwoodie SL
Circ Genom Precis Med; 2018 Mar; 11(3):e001978. PubMed ID: 29555671
[TBL] [Abstract][Full Text] [Related]
53. Identification of clinically actionable variants from genome sequencing of families with congenital heart disease.
Alankarage D; Ip E; Szot JO; Munro J; Blue GM; Harrison K; Cuny H; Enriquez A; Troup M; Humphreys DT; Wilson M; Harvey RP; Sholler GF; Graham RM; Ho JWK; Kirk EP; Pachter N; Chapman G; Winlaw DS; Giannoulatou E; Dunwoodie SL
Genet Med; 2019 May; 21(5):1111-1120. PubMed ID: 30293987
[TBL] [Abstract][Full Text] [Related]
54. R25C mutation in the NKX2.5 gene in Italian patients affected with non-syndromic and syndromic congenital heart disease.
Beffagna G; Cecchetto A; Dal Bianco L; Lorenzon A; Angelini A; Padalino M; Vida V; Bhattacharya S; Stellin G; Rampazzo A; Daliento L
J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):582-6. PubMed ID: 22964646
[TBL] [Abstract][Full Text] [Related]
55. Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.
Welch CL; Austin ED; Chung WK
Pediatr Pulmonol; 2021 Mar; 56(3):614-620. PubMed ID: 31917901
[TBL] [Abstract][Full Text] [Related]
56. Congenital heart defects and developmental and other psychiatric disorders: a Danish nationwide cohort study.
Olsen M; Sørensen HT; Hjortdal VE; Christensen TD; Pedersen L
Circulation; 2011 Oct; 124(16):1706-12. PubMed ID: 21947292
[TBL] [Abstract][Full Text] [Related]
57. Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease.
Blauwendraat C; Reed X; Kia DA; Gan-Or Z; Lesage S; Pihlstrøm L; Guerreiro R; Gibbs JR; Sabir M; Ahmed S; Ding J; Alcalay RN; Hassin-Baer S; Pittman AM; Brooks J; Edsall C; Hernandez DG; Chung SJ; Goldwurm S; Toft M; Schulte C; Bras J; Wood NW; Brice A; Morris HR; Scholz SW; Nalls MA; Singleton AB; Cookson MR;
JAMA Neurol; 2018 Nov; 75(11):1416-1422. PubMed ID: 30039155
[TBL] [Abstract][Full Text] [Related]
58. Targeted Next-Generation Sequencing in Patients with Non-syndromic Congenital Heart Disease.
Pulignani S; Vecoli C; Borghini A; Foffa I; Ait-Alì L; Andreassi MG
Pediatr Cardiol; 2018 Apr; 39(4):682-689. PubMed ID: 29332214
[TBL] [Abstract][Full Text] [Related]
59. Exome sequencing reveals novel IRXI mutation in congenital heart disease.
Guo C; Wang Q; Wang Y; Yang L; Luo H; Cao XF; An L; Qiu Y; Du M; Ma X; Li H; Lu C
Mol Med Rep; 2017 May; 15(5):3193-3197. PubMed ID: 28358424
[TBL] [Abstract][Full Text] [Related]
60. Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data.
Glessner JT; Bick AG; Ito K; Homsy J; Rodriguez-Murillo L; Fromer M; Mazaika E; Vardarajan B; Italia M; Leipzig J; DePalma SR; Golhar R; Sanders SJ; Yamrom B; Ronemus M; Iossifov I; Willsey AJ; State MW; Kaltman JR; White PS; Shen Y; Warburton D; Brueckner M; Seidman C; Goldmuntz E; Gelb BD; Lifton R; Seidman J; Hakonarson H; Chung WK
Circ Res; 2014 Oct; 115(10):884-896. PubMed ID: 25205790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
